Evidence map›Paper›PMID 41919730›Full record

ArticleEuropean journal of psychotraumatology2026

Trauma re-experiencing episodes during esketamine treatment in patients with treatment-resistant depression and comorbid PTSD: a retrospective case series.

Maud Rothärmel, Lila Mekaoui, François Kazour, Morgane Herrero, Eva-Maria Beetz-Lobono, Aiste Lengvenyte, Jérôme Holtzmann, Philippe Raynaud, Macarena Cuenca, Samuel Bulteau and 14 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of psychotraumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Maud RothärmelUniversity Department of Psychiatry, Therapeutic Centre of Excellence, Institute of Psychiatry - Rouvray Hospital Centre, Sotteville-lès-Rouen, France.ORCID 0000-0002-1947-0403
Lila MekaouiMental and Brain Illness Clinic, Sainte-Anne Hospital, GHU Paris - Psychiatry and Neurosciences, Paris, France.
François KazourDepartment of Psychiatry and Addictology, CHU Angers, Angers, France.
Morgane HerreroDepartment of Psychiatry, CHU Saint Etienne, Saint Etienne, France.
Eva-Maria Beetz-LobonoCentre Hospitalier Princesse Grace, Service de psychiatrie, Principauté de Monaco, France.
Aiste LengvenyteDepartment of Emergency Psychiatry and Post-Acute Care, CHU Montpellier, Montpellier, France.
Jérôme HoltzmannService de Psychiatrie de l'Adulte, Centre Expert Dépression Résistante FondaMental, CHU de Grenoble, Hôpital Nord, Grenoble, France.
Philippe RaynaudDepartment of Psychiatry, Thuir Hospital Centre, Thuir, France.
Macarena CuencaUniversity Department of Psychiatry, Pôle Hospitalo-Universitaire Psychiatrie Paris 15, Groupe Hospitalier Universitaire Paris, Paris, France.
Samuel BulteauNantes Université, CHU Nantes, INSERM, MethodS in Patients-centered outcomes and HEalth Research, SPHERE, Nantes, France.
Pierre De MaricourtUniversity Department of Psychiatry, Pôle Hospitalo-Universitaire Psychiatrie Paris 15, Groupe Hospitalier Universitaire Paris, Paris, France.
Thomas HussonUniversity Department of Psychiatry, Therapeutic Centre of Excellence, Institute of Psychiatry - Rouvray Hospital Centre, Sotteville-lès-Rouen, France.
Emilie OliéDepartment of Emergency Psychiatry and Post-Acute Care, CHU Montpellier, Montpellier, France.
Bénédicte GohierDepartment of Psychiatry and Addictology, CHU Angers, Angers, France.
Anne SauvagetNantes Université, CHU Nantes, INSERM, MethodS in Patients-centered outcomes and HEalth Research, SPHERE, Nantes, France.
Raphaël GaillardUniversity Department of Psychiatry, Pôle Hospitalo-Universitaire Psychiatrie Paris 15, Groupe Hospitalier Universitaire Paris, Paris, France.
Raphaëlle RichieriService Universitaire de santé mentale et physique, Centre Expert Dépression Résistante, CHU Sainte-Marguerite, APHM, Université Aix-Marseille, Marseille, France.
David SzekelyCentre Hospitalier Princesse Grace, Service de psychiatrie, Principauté de Monaco, France.
Ludovic SamalinDepartment of Psychiatry, CHU Clermont-Ferrand, University of Clermont Auvergne, CNRS, Clermont Auvergne INP, Institut Pascal (UMR 6602), Clermont-Ferrand, France.
Olivier GuillinUniversity Department of Psychiatry, Therapeutic Centre of Excellence, Institute of Psychiatry - Rouvray Hospital Centre, Sotteville-lès-Rouen, France.
Virginie MoulierUniversity Department of Psychiatry, Therapeutic Centre of Excellence, Institute of Psychiatry - Rouvray Hospital Centre, Sotteville-lès-Rouen, France.
Wissam El-HageCentre Régional de Psychotraumatologie, Centre Hospitalier Régional Universitaire (CHRU) de Tours, Tours, France.
Andrew LaurinNantes Université, CHU Nantes, INSERM, MethodS in Patients-centered outcomes and HEalth Research, SPHERE, Nantes, France.
Lucie BerkovitchUniversity Department of Psychiatry, Pôle Hospitalo-Universitaire Psychiatrie Paris 15, Groupe Hospitalier Universitaire Paris, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Depressive Disorder, Treatment-ResistantKetamineStress Disorders, Post-TraumaticAdultAntidepressive AgentsComorbidityFemaleHumansMaleMiddle AgedRetrospective StudiesAntidepressive AgentsEsketamineKetaminedepresión resistente a tratamientoesketamine nasal sprayEspray nasal de esketaminapost-traumatic stress disorderreal-life datareexperimentación traumáticatrastorno de estrés postraumáticotraumatic re-experiencingTreatment-resistant depression

Identifiers

PMID41919730
PMCPMC13045195

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.